Publications by authors named "Alan Koletsky"

Claim this Profile
A
Androgen Receptor Modulation Optimized for Response (ARMOR) Phase I and II Studies: Galeterone for the Treatment of Castration-Resistant Prostate Cancer.
Bruce Montgomery, Mario A Eisenberger, Matthew B Rettig, Franklin Chu, Roberto Pili, Alan J Koletsky

Clin Cancer Res· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Docetaxel and carboplatin as first-line therapy in advanced non-small cell lung carcinoma: a phase II study.
Mohammad Jahanzeb, Greg Sarna, Robert Hirsch, Peter Radice, Alan Koletsky

Anticancer Res· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of vinorelbine and low-dose docetaxel in chemotherapy-naive patients with hormone-refractory prostate cancer.
Alan J Koletsky, Manuel L Guerra, Lori Kronish

Cancer J· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of weekly vinorelbine and trastuzumab as first-line therapy in patients with HER2(+) metastatic breast cancer.
Mohammad Jahanzeb, Joanne E Mortimer, Furhan Yunus, David H Irwin, James Speyer, Alan J Koletsky

Oncologist· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second Neoplasms in Patients With Hodgkin's Disease Following Combined Modality Therapy-The Yale Experience.
Alan J Koletsky, Joseph R Bertino, Leonard R Farber, Leonard R Prosnitz, Daniel S Kapp

J Clin Oncol· May 1986

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis